4//SEC Filing
WHITMAN BURKE W 4
Accession 0001209191-21-059153
CIK 0001178879other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 7:00 PM ET
Size
5.2 KB
Accession
0001209191-21-059153
Insider Transaction Report
Form 4
WHITMAN BURKE W
Director
Transactions
- Purchase
Common Stock
2021-10-01$9.56/sh+1,500$14,346→ 63,582 total
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $9.45 to $9.58. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001188191
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 7:00 PM ET
- Size
- 5.2 KB